A multi-center retrospective study on the efficacy and safety of regorafenib plus immune checkpoint inhibitors with or without TACE as a second-line treatment for advanced hepatocellular carcinoma.

CVM TV’s head of marketing, Andrew Brown has departed the media company after three years in the role, closing a chapter marked by bold brand transformation and renewed audience engagement. Brown ...

A phase 1 dose escalation study of eFT508, an inhibitor of mitogen-activated protein kinase-interacting serine/threonine kinase-1 (MNK-1) and MNK-2 in patients with advanced solid tumors. Molecular ...

Tracey Forfa, a 30-year veteran of the Food and Drug Administration, will become the new director of FDA’s Center for Veterinary Medicine. She has been CVM’s acting director since December, when ...

As the saying goes, there are many possible reasons for an insider to sell a stock, but only one reason to buy -- they expect to make money. So let's look at two noteworthy recent insider buys. At CEL ...

Celebrating a ribbon-cutting ceremony Aug. 17 for the MSU College of Veterinary Medicine’s newly renovated and expanded Animal Emergency & Referral Center are, from left to right, Associate Dean Ron ...